| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| ITCI | $94.87 | 14.91% | 4,079 | 565 | $10,058 | $70.49 | 34.6% |
Intra-Cellular Therapies, Inc.
430 East 29th Street
New York, NY 10016
United States
Intra-Cellular Therapies, Inc. is a biopharmaceutical company founded on Nobel prize-winning research that allows it to understand how therapies affect the inner-workings of cells in the body. The Company leverages this intracellular approach to deliver innovative treatments for people living with complex psychiatric and neurologic diseases.